{
    "xml": "<topic id=\"PHP1517\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/protamine-sulfate\" basename=\"protamine-sulfate\" title=\"PROTAMINE SULFATE\">\n<title>PROTAMINE SULFATE</title>\n<body>\n<data name=\"vtmid\">350083007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_692423180\" title=\"Chelators and antidotes\">Chelators and antidotes</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP46094\" outputclass=\"indicationsAndDose\" rev=\"1.34\" parent=\"/drugs/protamine-sulfate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Overdosage with intravenous injection of unfractionated heparin</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Dose to be administered at a rate not exceeding 5&#8239;mg/minute, 1&#8239;mg neutralises 80&#8211;100&#8239;units heparin when given within 15&#8239;minutes; if longer than 15&#8239;minute since heparin, less protamine required (consult product literature for details) as heparin rapidly excreted; maximum 50&#8239;mg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Overdosage with intravenous infusion of unfractionated heparin</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>25&#8211;50&#8239;mg, to be administered once heparin infusion stopped at a rate not exceeding 5&#8239;mg/minute.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Overdosage with subcutaneous injection of unfractionated heparin</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 25&#8211;50&#8239;mg, to be administered at a rate not exceeding 5&#8239;mg/minute, 1&#8239;mg neutralises 100&#8239;units heparin, then (by intravenous infusion), any remaining dose to be administered over 8&#8211;16 hours; maximum 50&#8239;mg per course.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Overdosage with subcutaneous injection of low molecular weight heparin</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by continuous intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Dose to be administered by intermittent intravenous injection at a rate not exceeding 5&#8239;mg/minute, 1&#8239;mg neutralises approx. 100&#8239;units low molecular weight heparin (consult product literature of low molecular weight heparin for details); maximum 50&#8239;mg.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46142\" outputclass=\"cautions\" rev=\"1.13\" parent=\"/drugs/protamine-sulfate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Excessive doses can have an anticoagulant effect</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46060\" outputclass=\"sideEffects\" rev=\"1.9\" parent=\"/drugs/protamine-sulfate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaphylaxis</ph>; <ph outputclass=\"sideEffect\">angioedema</ph>; <ph outputclass=\"sideEffect\">back pain</ph>; <ph outputclass=\"sideEffect\">bradycardia</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">lassitude</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">pulmonary oedema</ph>; <ph outputclass=\"sideEffect\">rebound bleeding</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46154\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.19\" parent=\"/drugs/protamine-sulfate\">\n<title>Allergy and cross-sensitivity</title>\n<body>\n<section outputclass=\"allergyAndCrossSensitivityCrossSensitivity\">\n<sectiondiv>\n<p>Caution if increased risk of allergic reaction to protamine (includes previous treatment with protamine or protamine insulin, allergy to fish, men who are infertile or who have had a vasectomy and who may have antibodies to protamine).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46023\" outputclass=\"monitoringRequirements\" parent=\"/drugs/protamine-sulfate\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor activated partial thromboplastin time or other appropriate blood clotting parameters.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57188\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/protamine-sulfate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>The long half-life of low molecular weight heparins should be taken into consideration when determining the dose of protamine sulfate; the effects of low molecular weight heparins can persist for up to 24 hours after administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1517-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/protamine-sulfate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77291\" title=\"Solution for injection\" namespace=\"/drugs/protamine-sulfate/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78403\" namespace=\"/treatment-summaries/venous-thromboembolism\" title=\"Venous thromboembolism\" count=\"1\" rel=\"backlink\">Venous thromboembolism</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77291\" namespace=\"/drugs/protamine-sulfate/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP1517",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/protamine-sulfate",
    "basename": "protamine-sulfate",
    "title": "PROTAMINE SULFATE",
    "vtmid": "350083007",
    "drugClassification": [
        "Chelators and antidotes"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Overdosage with intravenous injection of unfractionated heparin",
                        "html": "Overdosage with intravenous injection of unfractionated heparin"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Dose to be administered at a rate not exceeding 5 mg/minute, 1 mg neutralises 80&#8211;100 units heparin when given within 15 minutes; if longer than 15 minute since heparin, less protamine required (consult product literature for details) as heparin rapidly excreted; maximum 50 mg.",
                        "html": "<p>Dose to be administered at a rate not exceeding 5&#8239;mg/minute, 1&#8239;mg neutralises 80&#8211;100&#8239;units heparin when given within 15&#8239;minutes; if longer than 15&#8239;minute since heparin, less protamine required (consult product literature for details) as heparin rapidly excreted; maximum 50&#8239;mg.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Overdosage with intravenous infusion of unfractionated heparin",
                        "html": "Overdosage with intravenous infusion of unfractionated heparin"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "25&#8211;50 mg, to be administered once heparin infusion stopped at a rate not exceeding 5 mg/minute.",
                        "html": "<p>25&#8211;50&#8239;mg, to be administered once heparin infusion stopped at a rate not exceeding 5&#8239;mg/minute.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Overdosage with subcutaneous injection of unfractionated heparin",
                        "html": "Overdosage with subcutaneous injection of unfractionated heparin"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 25&#8211;50 mg, to be administered at a rate not exceeding 5 mg/minute, 1 mg neutralises 100 units heparin, then (by intravenous infusion), any remaining dose to be administered over 8&#8211;16 hours; maximum 50 mg per course.",
                        "html": "<p>Initially 25&#8211;50&#8239;mg, to be administered at a rate not exceeding 5&#8239;mg/minute, 1&#8239;mg neutralises 100&#8239;units heparin, then (by intravenous infusion), any remaining dose to be administered over 8&#8211;16 hours; maximum 50&#8239;mg per course.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Overdosage with subcutaneous injection of low molecular weight heparin",
                        "html": "Overdosage with subcutaneous injection of low molecular weight heparin"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or continuous intravenous infusion"
                    ],
                    "textContent": "By intravenous injection or by continuous intravenous infusion",
                    "html": "By intravenous injection or by continuous intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Dose to be administered by intermittent intravenous injection at a rate not exceeding 5 mg/minute, 1 mg neutralises approx. 100 units low molecular weight heparin (consult product literature of low molecular weight heparin for details); maximum 50 mg.",
                        "html": "<p>Dose to be administered by intermittent intravenous injection at a rate not exceeding 5&#8239;mg/minute, 1&#8239;mg neutralises approx. 100&#8239;units low molecular weight heparin (consult product literature of low molecular weight heparin for details); maximum 50&#8239;mg.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Excessive doses can have an anticoagulant effect",
                "html": "Excessive doses can have an anticoagulant effect"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Anaphylaxis",
                        "html": "Anaphylaxis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "angioedema",
                        "html": "angioedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "back pain",
                        "html": "back pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bradycardia",
                        "html": "bradycardia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "lassitude",
                        "html": "lassitude",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pulmonary oedema",
                        "html": "pulmonary oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rebound bleeding",
                        "html": "rebound bleeding",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "allergyAndCrossSensitivity": {
        "crossSensitivity": [
            {
                "type": "crossSensitivity",
                "textContent": "Caution if increased risk of allergic reaction to protamine (includes previous treatment with protamine or protamine insulin, allergy to fish, men who are infertile or who have had a vasectomy and who may have antibodies to protamine).",
                "html": "<p>Caution if increased risk of allergic reaction to protamine (includes previous treatment with protamine or protamine insulin, allergy to fish, men who are infertile or who have had a vasectomy and who may have antibodies to protamine).</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor activated partial thromboplastin time or other appropriate blood clotting parameters.",
                "html": "<p>Monitor activated partial thromboplastin time or other appropriate blood clotting parameters.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "The long half-life of low molecular weight heparins should be taken into consideration when determining the dose of protamine sulfate; the effects of low molecular weight heparins can persist for up to 24 hours after administration.",
                "html": "<p>The long half-life of low molecular weight heparins should be taken into consideration when determining the dose of protamine sulfate; the effects of low molecular weight heparins can persist for up to 24 hours after administration.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77291",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78403",
                "label": "Venous thromboembolism",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77291",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}